Guideline values and human risk assessment for the presence of anti-inflammatory drugs remaining in drinking water after lab scale treatment. Braz. J. Pharm. Sci. [Internet]. 2018 Jun. 7 [cited 2024 May 5];54(1):e17320. Available from: https://www.revistas.usp.br/bjps/article/view/146840